FACULTY / 5th International Workshop on Lung Health

Stefano Aliberti

Stefano Aliberti is Associate Professor in Respiratory Medicine at the University of Milan and consultant at the Policlinico University Hospital, Milan, Italy. He received his medical degree from the University of Milan and completed his clinical research training at the University of Louisville, KY, USA, working as member of the Community-Acquired Pneumonia Organization Database. Most of his research over the past ten years has been focused on both acute and chronic respiratory infections. He is currently Head of the Respiratory Infections Assembly of the European Respiratory Society, co-funding member of both the European Registry (EMBARC) and the Italian Registry (IRIDE) of adult patients with bronchiectasis. He leads a multidisciplinary team of physicians and respiratory physiotherapists taking care bronchiectasis patients and those with NTM at the Policlinico Hospital.

Francesco Blasi

Francesco Blasi, MD, FERS, is Professor of Respiratory Medicine and Head of the Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Cardiothoracic Unit IRCCS Fondazione CĂ  Granda Ospedale Maggiore Milan.
His research interests include the effects of atypical bacterial infection on cellular immunity in chronic bronchitis, and the role of atypical bacteria and viral infection in asthma onset.
He is also interested in the role of antibiotics in the treatment of chronic obstructive pulmonary disease (COPD) exacerbations and asthma. He is actively working on pneumonia and tuberculosis research trials.
Professor Blasi has published more than 230 papers in international journals.

Fulvio Braido

Prof. Fulvio Braido is Associate Professor of Allergy & Respiratory Diseases Department at the University of Genoa, Italy, where he is the Head of Respiratory Critical Care Unit and Sleep Breathing Disorders

Fulvio Braido graduated cum laude in 1993 at the School of Medicine, University of Genoa and participated to the Residence Program in Respiratory Diseases in the period 1993-1997 and in Allergy and Clinical Immunology 2002-2006 at the University of Genoa.

He is investigator in clinical and experimental studies performed at the Allergy & Respiratory Diseases Department, University of Genoa, and his main research interests are represented by the physiopathological/immunological mechanisms and patient reported outcomes assessment in Rhinitis, Asthma, COPD and Sleep Apnea.

Fulvio Braido has an excellent experience in clinical trials according to Good Clinical Practice. He is heavily engaged in teaching activities for the School of Medicine in Genoa, where he teaches Respiratory Diseases.
He is member of the European Respiratory Society, Executive Committee Member of the Italian Respiratory Society, Executive Committee Member of the European Academy of Allergy & Clinical Immunology (EAACI), Chair of the European Accreditation Board in Allergology and Clinical Immunology (EBAACI), Executive Board member and Executive Vice President of the International Society of Asthmology (Interasma).
He is author of 138 peer-reviewed publications and co-author of several book chapters. Bibliometric parameters at Jan 2016: H-Index (Google Scholar: 24; Scopus; Web of Science: 19). i10-index (Google Scholar): 44; i10-index since 2011 (Google Scholar):43. Overall Citations: 2150 (Google Scholar); Average Citations per Item (WoS): 8.72. Overall Impact Factor: 344.

Guy Brusselle

Guy Brusselle received his medical degree (M.D.) at Ghent University in 1990. Investigating the functional role of cytokines interleukin-4 (IL-4) and interleukin-5 (IL-5) in allergic asthma, he obtained his Ph.D. in 1997. As a respiratory physician with a keen clinical and scientific interest in asthma, severe asthma and COPD, he joined the Ghent University Hospital in 2002. Since 2008, he is professor of medicine at Ghent University, teaching “Study design” and “Immunopathology of airway diseases” to medical and biomedical students, respectively. Since 2015, he teaches the course “Methods and design of clinical studies” to master students in pharmaceutical sciences. Currently, he is head of the Laboratory for Translational Research of Obstructive Pulmonary Diseases at Ghent University. From September 2012 to October 2015, he has served the European Respiratory Society (ERS) as Guidelines Director. Since September 2016, he is the chair of the ERS Science Council. Read More >

Giorgio Walter Canonica

Professor Giorgio Walter Canonica is Chairman of the Dept of Medical Specialties at the University Hospital S. Martino Genoa. He is also Director of the Allergy & Respiratory Diseases Clinic, Genoa University Italy a Galen Centre of Excellence. Professor Canonica initially specialised in pulmonary diseases after having received his medical degree from the University of Genoa, he then specialised in Allergy and Clinical Immunology at Florence University.
Professor Canonica’s research interests include examination of the molecular events and interactions between immunocompetent cells, inflammatory cells and epithelial cells in allergic inflammation and airway remodelling.

Mario Cazzola

Mario Cazzola is Honorary Professor of Respiratory Medicine at the University of Rome Tor Vergata, Italy and Visiting Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK.

He is serving as Editor-in-chief of Pulmonary Pharmacology & Therapeutics and as an Associate Editor of Respiratory Medicine and Respiratory Research. He is a Section Head of Respiratory Pharmacology at F1000Prime, and a member of the Editorial Boards of Lancet Respiratory Medicine, Drugs, Respiration, COPD, International Journal of Chronic Obstructive Pulmonary Disease, and npj Primary Care Respiratory Medicine.

Prof. Cazzola is a fellow of the European Respiratory Society. He has received the 2015 European Respiratory Society Lifetime Achievement Assembly Award.

Stefano Centanni

Prof. Stefano Centanni studied medicine at the School of Medicine of the University of Milan, where he received his Medical Doctor Degree in 1979. Following an internship at the pulmonary Division of the McMaster University, Hamilton, Canada, in 1981 and a fellowship at the Pulmonary Division of the Mount Sinai Medical Center at the University of Miami, Florida, USA, in 1982, he specialized in Allergology at the University of Medicine of Pavia, Italy, in 1985.
He received a PhD in Pulmonary Diseases in 1998 at the University of Milan Medical School.
From 1990 to 1996 he worked as Assistant Professor of the University of Milan at the Pulmonary Division of the Maggiore Hospital, Milan, and from 1996 to 2005 as Associate Professor at the Pulmonary Division of the San Paolo Hospital, University of Milan. Since 1996 he is Chief of the Pulmonary Division of the San Paolo Hospital, Milan, and in 2005 he became full professor of Respiratory Medicine at the University of Milan.
Professor Centanni was Italian National Delegate 2007/2009 at the ERS and FERS Italian National Delegate from 2007 until 2012 and President of SIMeR (Italian Society of Respiratory Medicine – 2009/2011). Professor Centanni is author of more than one hundred scientific publications in international journals and several book chapters and books in the field of Respiratory Medicine.

James D. Chalmers

Professor James Chalmers is GSK/British Lung Foundation Professor of Respiratory Research and Honorary Consultant Respiratory Physician at the University of Dundee/Ninewells Hospital, Dundee.

His interests are in difficult airways disease, particularly bronchiectasis, COPD and severe asthma. He is chair of the European Bronchiectasis Registry (EMBARC) and chaired the recent European Bronchiectasis Guidelines. He is chair of the BTS Respiratory Infection SAG and is the incoming deputy chief editor of the European Respiratory Journal. In 2017 he won the Patrick Neil Medal from the Royal Society of Edinburgh and the Romain Pauwels award from the European Respiratory Society for his contribution to bronchiectasis research.

Ryan Dermot

Dermot Ryan is a recently retired GP from the UK. He has had a long standing interest in Primary Care Respiratory Disease and Allergy. He established the Primary Care professorial unit at the University of Aberdeen and was instrumental in the foundation of the journal npjPrimary Care Respiratory Medicine. He has latterly been the chair of the Primary Care Interest Group of the European Academy of Allergy and Clinical Immunology where ie was actively involved in the creation of the recent AIT guidelines. He is currently an Honorary Clinical Research Fellow at the University of Edinburgh and President of the Respiratory Effectiveness Group.

Fabiano Di Marco

Fabiano Di Marco, pulmonologist working in Hospital San Paolo in Milan, is Associate Professor of the University of Milan. His primary research interests include lung pathophysiology, COPD, asthma, invasive and noninvasive mechanical ventilation. He has published more than 70 papers in international peer reviewed journals, and is an Associate Editor of BMC Pulmonary Medicine.

David Heigener

David F. Heigener is consultant in the department of thoracic oncology at the LungenClinic Grosshansdorf, -the largest lung cancer center in Northern Germanyand head of the palliative care team. His main interest is medical treatment of lung cancer. He participated in numerous trials in this field with about 100 publications and book contributions. Besides that, he is member of the palliative care task force in the German respiratory society and responsible physician for interventional bronchology in the department. David F. Heigener is Member of IASLC, ASCO, ESMO, German Respiratory Society (DGP), German Cancer Society (DKG) and German Society for Palliative Medicine (DGP). He is member of the Editorial Board of “Atemwegs- und Lungenkrankheiten” and Reviewer for “Lung Cancer”, “Respiratory Medicine”, “Annals of Oncology”, “British Medical Journal”, “Journal of Clinical Oncology” and “Journal of Thoracic Oncology” Read More >

Felix Herth

Herth, Felix JF

Full Professor of Medicine, University of Heidelberg


Thoraxklinik-University of Heidelberg

Chairman and Head

Department of Pulmonology and Critical Care Medicine

Translational Lung Resaerch Center Heidelberg

Member of the German Lung Research Foundation (DZL)

Read More >

Stephen Holgate

Stephen Holgate is Medical Research Council Clinical Professor of Immunopharmacology at the Faculty of Medicine, Southampton, UK. He set up a research group focused on the mechanisms of asthma. He has utilized many approaches to study this disease including epidemiology, genetics, pathology, microbiology and immunology, pharmacology and experimental medicine. This research has informed guidelines on asthma management and has identified and validated novel therapeutic targets. Notable research contributions include the role of mast cells and their mediators in asthma and allied disorders, the regulation and pharmacology of mast cells, placing inflammation at the core of asthma pathophysiology, uncovering the role of respiratory viruses, allergens and pollutants in asthma exacerbation, the discovery of defects in innate immune responses in asthmatic airways, mechanisms of airway wall remodeling and the discovery of novel asthma susceptibility genes such as ADAM33. He is a Past President of the British Society of Allergy and Clinical Immunology and British Thoracic Society, Chairs the MRC Translational Research Group and the ERS Science Council.

Michael Loebinger

José Lopez - Campos

  • Pulmonologist at Hospital Universitario Virgen del RocĂ­o, Seville, Spain, in charge of a monographic COPD and bronchiectasis outpatient clinic.
  • Associate Professor of Medicine at Seville’s University.
  • Tutor of residents of Pneumology at Hospital Universitario Virgen del RocĂ­o, Seville, Spain.
  • Head of a research group linked to the CIBER of Respiratory Diseases, Ministry of Economy, Spain

Read More >

Massimo Pistolesi

  • University of Florence, Professor of Respiratory Medicine (1997 – )
  • Head of the Thoracic Section of the Cardiothoracic and vascular Department Careggi University Hospital, Florence (2014 – )
  • University of Pisa, Associate Professor of Respiratory Pathophysiology (1991 -1996)
  • University of Rome “Tor Vergata”, Associate Professor of Respiratory Pathophysiology (1988-1991)
  • National Research Council ( CNR) Institute of Clinical Physiology, Pisa , Career Investigator (1975- 1987)
  • Euratom fellowship, CNR Institute of Clinical Physiology, Pisa  

Read More >

Luca Richeldi

Professor Luca Richeldi is Professor of Respiratory Medicine, Chair of Interstitial Lung Disease within Medicine at the University of Southampton.

Born and bred in Modena, northern Italy, Luca Richeldi obtained his MD degree from the School of Medicine of the University of Modena in 1988. During his PhD program in Rome, he developed a scientific interest in the area of interstitial lung diseases (ILD), a group comprising several acute and chronic lung disorders, characterized by a poor prognosis and the lack of effective treatments so far. Over the following years, Luca continued to be active in this field through international collaborations and participating in different studies dealing with diagnosis and treatment of ILD, with a particular interest for idiopathic pulmonary fibrosis (IPF), the most common and most lethal among all ILD. In 2005, as Associate Professor of Respiratory Medicine at the University Hospital of Modena, he founded and led the Centre for Rare Lung Disease.

His research activity started with a study exploring the genetic susceptibility factors involved in the development of a rare occupational form of progressive ILD, chronic beryllium disease. This led to the publication in Science of the association between a single genetic polymorphism and the disease. The interest for fibrotic lung disorders continued with the study of the effects of pharmacologic treatments in IPF. By using the methodologies of the evidence-based medicine and the statistical tool of meta-analysis, Luca published, as leading author, two Cochrane systematic reviews, critically assessing the low level of evidence for pharmacologic treatments empirically used until then. He has also been involved in the production of evidence-based international guidelines, endorsed by all major international respiratory scientific societies, focusing on the management of patients with IPF and the classification of idiopathic interstitial pneumonias. These documents form the basis for the current diagnostic and therapeutic management of patients with ILD and for the design of randomized clinical trials in this rapidly expanding area of respiratory medicine. More recently, Luca led the publication of one of the most promising phase II clinical trials in IPF, published in The New England Journal of Medicine. He also had an interest in lung infections, particularly tuberculosis. In this field he contributed to the development and the evaluation of a new generation of diagnostic tests for latent tuberculosis: these results were published as leading author in The Lancet. He is on the editorial board of the American Journal of Respiratory and Critical Care Medicine and is an associate editor for the European Respiratory Journal. Luca is member of the Fleischner Society.

Appointments held

  • Associate Professor of Respiratory Medicine, University of Modena and Reggio Emilia (Italy)
  • Director of the Centre for Rare Lung Diseases, University Hospital of Modena (Italy)

Read More >

Nicolas Roche

Nicolas Roche is Professor of Respiratory Medicine at Cochin Hospital, University of Paris Descartes, Paris, France. He graduated in medicine in 1994 and obtained his PhD in 2003. He spent a year as a research fellow at Imperial College London, London, UK. His major areas of interest are chronic obstructive pulmonary disease (COPD), asthma, inhaled therapy and real-life research.

Professor Roche coordinates epidemiological research projects as well as a dedicated nationwide clinical research group. His clinical research topics include the study of disease phenotypes, the development of new clinical assessment tools and the evaluation of treatment strategies for COPD and asthma.

He is involved in national public health initiatives on COPD. He participated in the development of French guidelines on asthma and education of asthmatic adults, coordinates the French guidelines on COPD. He is a member of the Global Initiative on Obstructive Lung Disease science committee and the executive committee of the Respiratory Effectiveness Group.

Professor Roche has authored more than 250 articles in international peer-reviewed journals and edited or co-edited several books on COPD, including articles on inhalation therapy for asthma and COPD. He is Vice-President of Société de Pneumologie de Langue Française, member of the Clinical Research Collaboration working group of the European Respiratory Society and member of the American Thoracic Society. He has been Chief Editor of Revue des Maladies Respiratoires, and is Associate Editor of the European Respiratory Review and the Clinical Respiratory Journal.

Pierachille Santus

Pierachille Santus is currently Associate Professor in Respiratory Medicine at the University of Milano, Italy and Head of Respiratory Division at “L. Sacco” University Hospital-ASST Fatebenefratelli Sacco Milano, Italy.

He graduated in 1996 at the School of Medicine, University of Milano and participated to the Residence Programme in Respiratory Diseases in the period 1996-2000 at the same University. Prof. Santus obtained his Ph.D on Molecular Biology-Curricula Molecular Oncology at the University of Milano, Italy in 2004. In the 2001, Prof. Santus was a post-doctoral research fellow at the Aintree Chest Centre – University Aintree Hospital NHS, Fazakerly Hospital with Prof. P.M.A. Calverley MD (Liverpool-UK) and during the summer fellow at the Biomedical Engineering Centre of Boston University with Prof. K. Lutchen PhD (Boston-USA).

Prof. Santus work in a clinical setting managing all the acute and chronic respiratory diseases in terms of diagnosis (noninvasive and invasive technics) and therapy (eg noninvasive ventilation, biological and innovative drugs).  

He is principal investigator in clinical studies and international RCTs focused on COPD and asthma innovative treatment, and his main research interests are the clinical aspects of COPD and asthma, with special focus on the physiological and pathophysiological modifications that affected the lung mechanics, airways variability of subjects affected by chronic respiratory diseases. However, Prof. Santus have research interest also on the clinical pharmacology in COPD and Asthma, with particular focus on the molecular and pathophysiological modification related to bronchodilators.

Prof. Santus has an excellent experience, as principal investigators, in National and International clinical trials according to Good Clinical Practice. He is heavily engaged in teaching activities for the School of Medicine, Rehabilitation and Extracorporeal Cardiac Technicians in the University of Milano, where he teaches Respiratory Diseases.

He is member of the European Respiratory Society, the Italian Respiratory Society (head of the working group on chronicity and general management of respiratory diseases).

He is author of seventy-two peer-reviewed publications and co-author of several book chapters and monographs. Prof. Santus served as reviewer for many respiratory journals and he is Section Editor (Pulmunology) of the European Journal of Internal Medicine.

Giovanni Sotgiu

1996-1997: Medical Degree (110/110 cum laude);
2000-2001: Specialization in Infectious Diseases (50/50 cum laude);
2003-2004: PhD in “Methodology of Clinical Trials” (Excellent);
2006-2007: Specialization in Medical Statistics (50/50 cum laude).
2014-2015: Executive Master in Management of Health and Social Care Organizations.
2016: Fellow of European Respiratory Society (FERS)
Read More >

Nicola Sverzellati

Medical degree at the University of Bologna (2002)
Registrar in Radiology at the Academic Hospital of Parma (2002-2006)
PhD in “Advanced Cardio-Thoracic Imaging” at the University of Parma (2007-2010)
Research collaborator at the Royal Brompton Hospital of London (since 2005 )
Visitor at the Department of Radiology of the Vancouver General Hospital (May-June 2007)
Research collaboration at the National Cancer Institute of Milan for the lung cancer screening
project “Multicentric Italian Lung Detection” trial (since 2007)
Lecturer/Consultant at the University Hospital of Parma (2010-2014).
Associate Professor/Consultant at the University Hospital of Parma (2014 – )
Read More >

Antonio Torres

Born in Barcelona in 1954, he is Full Professor in Medicine (Pulmonology) at the University of Barcelona (UB) and Director of the Respiratory Intensive Care Unit at Hospital Clínic. He is considered a physician of reference both nationally and internationally in lung infections, chronic obstructive pulmonary disease , bronchiectasis, weaning of mechanical ventilation and acute respiratory distress syndrome (ARDS-ALI). He leads the research group on Applied Research in Respiratory Diseases of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), from where he facilitates translational research studies. He also coordinates a CIBER group on respiratory diseases (Ciberes), an SGR (Generalitat de Catalonia) group and participates in several European projects. He is author of more than 1200 scientific publications and has supervised 34 Phd theses. He has a Hirsch index of 94. Several clinical key findings of his group have been translated to clinical practice.

Johann Christian Virchow

J .Christian Virchow, MD, FRCP, FCCP, FAAAAI, is a Professor of Medicine and Pneumology and Head of the Departments of Pulmonary Medicine and Intensive Care Medicine in the University Medical Clinic at the University of Rostock, Germany. He is also the Medical Director of the Pulmonary Diagnostic Services and the Sleep Laboratory of the University of Rostock. He is Editor-in-Chief of RESPIRATORY MEDICINE and Visiting Professor of the China-Japan-friendship hospital in Beijing, PR China. He is a member of several medical organizations, including the American Thoracic Society, the European Respiratory Society, and the American College of Chest Physicians. Dr. Virchow serves as Associate Editor for several German journals in pulmonology and allergology and has served as an ad hoc reviewer for Chest, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the European Respiratory Journal and many others. He is the author or coauthor of more than 200 peer reviewed articles for journals such as JAMA, the American Journal of Respiratory and Critical Care Medicine, Chest, and European Respiratory Journal and author of several chapters for text books. He received his doctoral degree from the University of Tübingen, Germany after attending Medical School in Marburg and Giessen, Germany and Zürich, Switzerland. Dr. Virchow completed his residency in internal medicine at University Medical Clinic in Freiburg, Germany, and his fellowship in pulmonary medicine at the Department of Pneumology at the University of Freiburg, Germany under Prof. H. Matthys. His special interests are research into the mechanisms of inflammation in chronic obstructive lung diseases such as asthma and COPD as well as the treatment of these conditions.

Tobias Welte

Professor Tobias Welte is the Head of the Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover.
1978 -1985: Study of human medicine, Hannover Medical School
1985 – 88/90: Department of Internal Medicine, County Hospital Lehrte
1989: Residentialship, Massuchusetts General Hospital Boston, USA
1990-1994: Fellow, Department of Respiratory Medicine, Hannover Medical School
1992: Specialist for Internal Medicine
1994: Specialist for Respiratory Medicine
1994: MD
1995: Specialist Intensive Care Medicine
2000: Habilitation for “Internal Medicine”
2002: Specialist for Infectious Disease Academic Appointments:
1994 – 2004 : Head of the Division of Respiratory Medicine and Intensive Care, University of Magdeburg
2003: Appointment C3 Professorship for Respiratory Medicine University of Magdeburg, not accepted
since 2004: W3-Professorship, Head of the Department of Respiratory Medicine, Hannover Medical School
2015: Appointment Professorship for Pneumology, University of Vienna, not accepted Other (selected) Professional Activities:
1994 – today: Project leader in more than thirty research projects funded by DFG, BMBF and EU
Since 2001: Co-ordinating board of BMBF-competence networks PROGRESS, ASCONET and CAPNETZ as well as Chairman of CAPNETZ Foundation
2007-2011: Speaker of the BMBF funded Clinical Study Center Hannover (KS-MHH)
since 2011: Member of the board of directors of the German Center for Lung Research (DZL) and director of the Hannover DZL site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease Hannover)
since 2011: Member of the Internal Advisory Board of the German Center of Infectious Disease Research (DZIF)
2008-2010: President of the German Society of Medical Intensive Care Medicine
2009-2015: Chief Editor of the European Respiratory Monograph
since 2008: Member, since 2012 Spokesman of DFG-Fachkollegium “Inflammation”
2009-2013: President of the German Sepsis Society
2012-2014 President of German Society of Pneumology
Additional Information: 2014 Appointment as Fellow of the European Respiratory Society (FERS)